Chiang John

SEC source: 0001104659-26-073467 · tm2617575-1_4seq1.xml · nonDerivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,373

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

F2 · balance_after: Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001104659-25-078866 · tm2523581-1_4seq1.xml · derivative · entry 3

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2025-11-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These stock options were fully vested and exercisable.

SEC source: 0001104659-25-078866 · tm2523581-1_4seq1.xml · nonDerivative · entry 2

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,848

F2 · balance_after: Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.

SEC source: 0001104659-25-078866 · tm2523581-1_4seq1.xml · nonDerivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,132

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-25-059369 · tm2517874-2_4seq1.xml · nonDerivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,132

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders.

F2 · balance_after: Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.

SEC source: 0001104659-24-121026 · tm2428618-2_4seq1.xml · derivative · entry 3

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,515 shares

Expires 2024-11-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These stock options were fully vested and exercisable.

SEC source: 0001104659-24-121026 · tm2428618-2_4seq1.xml · nonDerivative · entry 2

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,683

F2 · balance_after: Includes 4,750 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders.

SEC source: 0001104659-24-121026 · tm2428618-2_4seq1.xml · nonDerivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,364

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-098980 · tm2423811-1_4seq1.xml · derivative · entry 3

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These stock options were fully vested and exercisable.

SEC source: 0001104659-24-098980 · tm2423811-1_4seq1.xml · nonDerivative · entry 2

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,849

F2 · balance_after: Includes 4,750 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders.

SEC source: 0001104659-24-098980 · tm2423811-1_4seq1.xml · nonDerivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-089692 · tm2421691-3_4seq1.xml · nonDerivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,414

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) August 13, 2025 or (ii) the date of the Issuer's 2025 annual meeting of stockholders.

F2 · balance_after: Includes 4,750 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders.

SEC source: 0001104659-23-126896 · tm2333076-1_4seq1.xml · nonDerivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,850

F1 · shares: Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors).

F2 · balance_after: Includes 4,750 shares of restricted stock, which will vest on December 9, 2024.

SEC source: 0001250853-22-000026 · primary_doc.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Underlying: Common Stock · 8,500 shares

Expires 2025-01-18

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022.

SEC source: 0001250853-20-000100 · primary_doc.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2025-11-11

F1 · derivative.exercise_date: The option vests in four equal quarterly installments from the option grant date.

SEC source: 0001104659-20-023833 · tm209648d7_4.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,578

Underlying: Common Stock · 1,578 shares

Expires 2024-11-25

F1 · derivative.exercise_price: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · kind: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · shares: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.exercise_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-20-023826 · tm209648-3_4a.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 900 shares

Expires 2024-11-25

F1 · derivative.exercise_price: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · kind: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · shares: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

F1 · derivative.exercise_date: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan.

SEC source: 0001104659-20-046379 · tm2015807d3_4a.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,515

Underlying: Common Stock · 1,515 shares

Expires 2024-11-25

F1 · derivative.exercise_price: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · kind: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.exercise_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.expiration_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · derivative.underlying_shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

F1 · balance_after: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 63 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024.

SEC source: 0001104659-19-075848 · tm1927354d3_4.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,900

Underlying: Common Stock · 900 shares

Expires 2024-11-25

F1 · derivative.exercise_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-19-065773 · tm1923454d3_4.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

SEC source: 0001553350-19-000653 · ownership.xml · nonDerivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100